Background Cost-effective primary prevention of cardiovascular disease (CVD) in low- and middle-income countries requires accurate risk assessment. Laboratory-based risk tools currently used in high-income countries are relatively expensive and impractical in many settings due to lack of facilities. Objectives This study sought to assess the correlation between a non-laboratory-based risk tool and 4 commonly used, laboratory-based risk scores in 7 countries representing nearly one-half of the world's population. Methods We calculated 10-year CVD risk scores for 47,466 persons with cross-sectional data collected from 16 different cohorts in 9 countries. The performance of the non-laboratory-based risk score was compared with 4 laboratory-bas...
Background-- Cardiovascular disease (CVD) risk scores that require laboratory testing (e.g., cholest...
Introduction: Estimation of the risk of cardiovascular diseases (CVD), may lead to prophylactic ther...
IntroductionCardiovascular disease (CVD) is the leading cause of death globally, representing 31% of...
Background Cost-effective primary prevention of cardiovascular disease (CVD) in low- and middle-inco...
National and international primary CVD risk screening guidelines focus on using total CVD risk score...
Background: All rigorous primary cardiovascular disease (CVD) prevention guidelines recommend absolu...
Background: Worldwide implementation of risk-based cardiovascular disease (CVD) prevention requires ...
BACKGROUND: Worldwide implementation of risk-based cardiovascular disease (CVD) prevention requires ...
It is unclear how well currently available risk scores predict cardiovascular disease (CVD) risk in ...
Background Cardiovascular diseases (CVD) are becoming major causes of death in developing countries....
BACKGROUND: Globorisk is a novel risk prediction model for predicting cardiovascular disease (CVD). ...
Background: Developing simplified risk assessment model based on non-laboratory risk factors that co...
Objective: To determine the agreement between the cardiovascular disease (CVD) risk predictions comp...
Background: European guidelines on primary prevention of cardiovascular disease (CVD) recommend the ...
Background Cardiovascular disease (CVD) is a major cause of mortality in HIV infected patients. Agr...
Background-- Cardiovascular disease (CVD) risk scores that require laboratory testing (e.g., cholest...
Introduction: Estimation of the risk of cardiovascular diseases (CVD), may lead to prophylactic ther...
IntroductionCardiovascular disease (CVD) is the leading cause of death globally, representing 31% of...
Background Cost-effective primary prevention of cardiovascular disease (CVD) in low- and middle-inco...
National and international primary CVD risk screening guidelines focus on using total CVD risk score...
Background: All rigorous primary cardiovascular disease (CVD) prevention guidelines recommend absolu...
Background: Worldwide implementation of risk-based cardiovascular disease (CVD) prevention requires ...
BACKGROUND: Worldwide implementation of risk-based cardiovascular disease (CVD) prevention requires ...
It is unclear how well currently available risk scores predict cardiovascular disease (CVD) risk in ...
Background Cardiovascular diseases (CVD) are becoming major causes of death in developing countries....
BACKGROUND: Globorisk is a novel risk prediction model for predicting cardiovascular disease (CVD). ...
Background: Developing simplified risk assessment model based on non-laboratory risk factors that co...
Objective: To determine the agreement between the cardiovascular disease (CVD) risk predictions comp...
Background: European guidelines on primary prevention of cardiovascular disease (CVD) recommend the ...
Background Cardiovascular disease (CVD) is a major cause of mortality in HIV infected patients. Agr...
Background-- Cardiovascular disease (CVD) risk scores that require laboratory testing (e.g., cholest...
Introduction: Estimation of the risk of cardiovascular diseases (CVD), may lead to prophylactic ther...
IntroductionCardiovascular disease (CVD) is the leading cause of death globally, representing 31% of...